Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $54.1202 (0.64%) ($53.1296 - $54.3011) on Mon. Jan. 26, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 46 | Latest Price | $54.1202(0.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) IBB(48%) VYM(48%) IVE(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.815% in a week (0% probabilities). VIXM(-23%) TLT(-15%) UUP(-8%) GLD(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
1 - 5 Day Possible Target | $50.43(-6.82%) | Resistance Level | $55.51 | 5 Day Moving Average | $54.16(-0.07%) | 10 Day Moving Average | $54.59(-0.86%) | 20 Day Moving Average | $55.51(-2.5%) | To recent high | -9.2% | To recent low | 5.5% | Market Cap | $95.483b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |